OBIO icon

Orchestra BioMed
OBIO

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$20
337% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Chardan Capital
Chardan Capital
Keay Nakae
43% 1-yr OBIO win rate
12 Mar ‘26 1 month ago